Nitric Oxide Production Assay Service
Nitric oxide (NO) is an essential neurotransmitter and signaling molecule, widely involved in physiological processes such as neurotransmission, vasodilation, and immune modulation. In multiple sclerosis (MS), NO plays a complex role, potentially exacerbating the disease through neurotoxicity while also providing protection by regulating immune and inflammatory responses. Our in vitro NO assay services, characterized by their efficiency, accuracy, and cost-effectiveness, are designed to meet the diverse needs of our clients. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
NO in Multiple Sclerosis (MS)
![]() |
Studies have demonstrated significantly elevated NO concentrations in the serum and cerebrospinal fluid of patients with MS. Furthermore, the expression of NO within the central nervous system (CNS) is closely correlated with disease progression. Notably, oligodendrocytes and motor neurons exhibit differential sensitivities to NO, with motor neurons displaying markedly higher sensitivity compared to oligodendrocytes. This disparity may influence the pathological mechanisms of MS, particularly the sequential events of axonal damage and myelin loss. |
Nitric Oxide Quantitation Assays
- Comprehensive NO Analysis for Diverse Research Needs
Our advanced NO detection services employ a multi-faceted approach, providing precise and reliable data for a wide range of applications.
Chemical Colorimetry
Leveraging the colorimetric reaction of NO metabolites (NO2-/NO3-), this method is versatile and compatible with various sample types, including cells, tissues, and serum. Achieves a detection limit in the μM range, enabling high-throughput screening for efficient analysis.
Enzyme Activity Analysis
Accurately assesses nitric oxide synthase (NOS) activity, providing critical insights into NO synthesis capacity in neural, endothelial, and other cell types.
Customized Integrated Analysis
Offers tailored solutions by combining NO detection with complementary techniques such as Western blot and ELISA. Enables joint analysis of NO pathway proteins (e.g., eNOS, iNOS) and oxidative stress markers (e.g., nitrotyrosine), providing a comprehensive understanding of NO signaling.
- Comprehensive End-to-End Support
Sample Pre-treatment Guidelines
Provision of standardized operational protocols for cell lysis, tissue homogenization, and other procedures to prevent sample degradation.
Data Interpretation Services
In-depth analysis of correlations between NO levels and disease phenotypes, leveraging comprehensive literature databases.
Case Study: NO production during the cell suspension subculture cycle
Fig.1 NO production within subcultivation period of Col-0 and ein2-1 cultures.2, 3
Empower your research with our streamlined in vitro nitric oxide testing services. We deliver efficient, accurate, and cost-effective solutions tailored to meet the diverse needs of our clientele. From fundamental research to cutting-edge drug development, our team provides expert technical support and unparalleled service quality.
Explore our comprehensive offerings and discover how we can accelerate your projects. Visit our website or contact us directly to learn more.
References
- Yuste, Jose Enrique, et al. "Implications of glial nitric oxide in neurodegenerative diseases." Frontiers in cellular neuroscience 9 (2015): 322.
- Novikova, Galina V., et al. "Nitric oxide has a concentration-dependent effect on the cell cycle acting via EIN2 in Arabidopsis thaliana cultured cells." Frontiers in Physiology 8 (2017): 142.
- Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)